A phase 1b randomized study of the safety and immunological responses to vaccination with H4:IC31, H56:IC31, and BCG revaccination in Mycobacterium tuberculosis-uninfected adolescents in Cape Town, South Africa
Journal article published in 2020 by
Linda-Gail Bekker,
One Dintwe,
Andrew Fiore-Gartland,
Keren Middelkoop 
,
Julia Hutter,
Anthony Williams,
April K. Randhawa,
Morten Ruhwald,
Ingrid Kromann,
Peter L. Andersen,
Carlos A. DiazGranados,
Kathryn T. Rutkowski,
Dereck Tait,
Maurine D. Miner,
Erica Andersen-Nissen
and other authors.
,
Julia Hutter,
Anthony Williams,
April K. Randhawa,
Morten Ruhwald,
Ingrid Kromann,
Peter L. Andersen,
Carlos A. DiazGranados,
Kathryn T. Rutkowski,
Dereck Tait,
Maurine D. Miner,
Erica Andersen-Nissen
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 